News
31 Jan 2020 - 20:36
Instruments & Events
Type
Ticker
ISIN
Market
SHARE
STABL
SE0013513652
Nasdaq First North Sweden
Type
Ticker
ISIN
Market
SHARE
STABL
SE0013513652
Nasdaq First North Sweden
Sweden (SE)
Details of share in Stayble Therapeutics AB with ticker STABL
Status
Inactive
Order book id
—
Amount of instruments
—
Par value
—
Market cap
—
Currency
SEK
First trading date
09 Mar 2020
Terms
—
Type
Price
Pre-money valuation
Time
12.30 SEK
50.02M SEK
04 Feb - 18 Feb 2020
Type
Price
Pre-money valuation
Time
12.30 SEK
50.02M SEK
04 Feb - 18 Feb 2020
IPO in Stayble Therapeutics AB
Market
Nasdaq First North Sweden
Subscription period
04 Feb - 18 Feb 2020
Subscription price
12.30 SEK
Price per share
12.30 SEK
Target to raise
35 055 000 SEK
Types
Share issue
Pre-money valuation
50 015 982 SEK
Subscription block size
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Upcoming
First trading date
09 Mar 2020
Issue terms
Open to the public.
Result of offer
The new issue of approximately SEK 35 million was subscribed for a total amount of SEK 153 million, corresponding to 436%. In connection to the new issue, Stayble received around 830 new shareholders.
Comments for offer & related information
One (1) unit consists of one (1) share and one (1) free subscription option, TO 1.
Each subscription option of the TO1 series, which is issued free of charge, entitles the holder to subscribe for a new share in the Company during the period from November 17 to December 1, 2020. The subscription price for subscription of shares based on subscription options amounts to the volume-weighted price of The Company's share during the period from 30 October to 13 November 2020 at a discount of 30 per cent, but not less than SEK 12.30 and a maximum of SEK 24.60.
Other documents
SE0013748381-R-2020.pdf
Type
Ticker
ISIN
Market
OPTION
STABL TO1
SE0013748381
Nasdaq First North Sweden
Type
Ticker
ISIN
Market
OPTION
STABL TO1
SE0013748381
Nasdaq First North Sweden
Sweden (SE)
Details of option in Stayble Therapeutics AB with ticker STABL TO1
Status
Inactive
Order book id
—
Amount of instruments
—
Market cap
—
Currency
SEK
First trading date
09 Mar 2020
Terms
One (1) subscription option of the TO1 series, entitles the holder to subscribe for a one (1) new share.
The subscription price for subscription of shares based on subscription options amounts to the volume-weighted price of The Company's share during the period from 30 October to 13 November 2020 at a discount of 30 per cent, but not less than SEK 12.30 and a maximum of SEK 24.60.
Type
Price
Pre-money valuation
Time
12.30-24.60 SEK
-
17 Nov - 01 Dec 2020
Type
Price
Pre-money valuation
Time
12.30-24.60 SEK
-
17 Nov - 01 Dec 2020
Option exercise terms for STABL TO1
Market
Nasdaq First North Sweden
Exercise period(s)
17 Nov - 01 Dec 2020
Exercise price range
12.30-24.60 SEK
Exercise final price
Status
Upcoming
Issue terms
One (1) subscription option of the TO1 series, entitles the holder to subscribe for a one (1) new share.
The subscription price for subscription of shares based on subscription options amounts to the volume-weighted price of The Company's share during the period from 30 October to 13 November 2020 at a discount of 30 per cent, but not less than SEK 12.30 and a maximum of SEK 24.60.
Other documents
SE0013513652-M-2020.pdf
People
Andreas Gerward
CEO
Catharina Bäärnhielm Marklund
Chairman of the board
Kjell Olmarker
Board member
Patrik Sjöstrand
Board member
Jane Laursen
Board member
Pontus Ottosson
Board member
Company Details
Sector
Website
Address
Medicinaregatan 8 A
Zip code
413 90
City/district
Gothenburg
Country
Sweden (SE)
Phones
Email
Registration number
5590248372
LEI code
549300WD23DE1US21868
First trade date
09 Mar 2020
Registration date
01 Sep 2015
Short name
Stayble Therapeutics